We studied the association between four novel single nucleotide polymorphisms (SNPs) in the promoter region of V1aR gene and essential hypertension in 620 Japanese subjects (365 hypertensives and 255 healthy). A significant association was found between one of the genotypes and alleles at SNP À6951 and hypertension in a subsample of nonobese individuals. This association demonstrated an independent risk for nonobese hypertension.
Arginine vasopressin (AVP) plays an important role in cardiovascular regulation. AVP acts on V1a receptor (V1aR) to increase vascular tone and baroreceptor sensitivity. 1, 2 Extensive studies have been made in the search for the genetic basis of essential hypertension. 3 V1aR gene also represents a reasonable candidate for the study of its involvement in human essential hypertension. Recently, it has become evident that in clinically defined subtypes of hypertension, obesity-associated hypertension may be genetically distinct from hypertension in nonobese individuals. 4 Since an investigation of clinically defined subsets of hypertension may facilitate the search for their specific genes, we explored whether the identified four novel single nucleotide polymorphisms (SNPs) of V1aR gene (À6951G/A, À4112A/T, À3860T/C and À242C/T) could be associated with either obesity-associated hypertension or hypertension in nonobese individuals.
All subjects were recruited from residents in Aomori prefecture. Informed consent was obtained from each subject and the Institutional Ethical Review Committee approved the study protocol. Blood pressure was measured in sitting position after at least 10 min of rest using a mercury sphygmomanometer. Hypertension was defined as an average systolic blood pressure (SBP) of 140 mm Hg or higher, an average diastolic blood pressure (DBP) of 90 mm Hg or higher and/or current use of antihypertensive medications. Hypertensive patients diagnosed with secondary hypertension were excluded. SBP and DBP of all healthy subjects were less than 140 and 90 mm Hg, respectively. Healthy subjects had no history of hypertension, body mass index (BMI) of o25 kg/m 2 and were without any medical treatments. All subjects had no history of diabetes mellitus, renal dysfunction, liver disease, malignancy, pregnancy and substance abuse, including alcohol. The definition of obesity was set to BMI of 25 kg/m 2 or higher according to the Japan Society for the Study of Obesity (JASSO). 5 Genomic DNA was assayed for the V1aR SNPs as described previously. 6 Genotype screening always included previously confirmed samples. Moreover, randomly selected samples from each group were sequenced to confirm genotyping accuracy.
Basic continuous characteristics between healthy control subjects and cases were analysed by Student's t-test. w 2 analysis with Yate's correction was applied to examine the differences in genotypes, alleles, haplotypes, as well as haplotype combinations between the groups. P-values presented are uncorrected for multiple testing unless otherwise stated. The SNPSpD method 7 was employed for correction of multiple SNP testing. To assess the independent contribution of confounding factors, logistic regression analysis was performed.
Both SBP and DBP were significantly higher in hypertensive patients than in healthy subjects. While the baseline characteristics of age and sex were not significantly different between the two groups, BMI, serum total cholesterol and serum total high-density lipoprotein (HDL) cholesterol were significantly different between hypertensive patients and healthy subjects (Supplementary Table 1 ). Genotype distributions at each of the four polymorphic sites of V1aR gene were in Hardy-Weinberg equilibrium in all subjects. There were no significant associations between genotypes or alleles of the V1aR polymorphisms and the risk of hypertension, when all cases were considered (Supplementary Table 2 ). However, when hypertensive patients were stratified according to obesity (BMIX25.0 kg/m ). The prevalence of GA þ AA genotype of SNP À6951 was significantly higher in NOB-HT compared with healthy subjects (P ¼ 0.016). This association remained significant after correction for multiple testing. A significance threshold of 0.017 was obtained for the four SNPs tested using the SNPSpD correction method of Nyholt. 7 The frequency of A allele of SNP À6951 was also significantly higher in NOB-HT compared with healthy subjects (P ¼ 0.019). However, allelic association was no longer significant after correction for multiple testing (Table 1a) . Multiple regression analysis revealed the significant association of SNP À6951G/A with NOB-HT (P ¼ 0.028) after adjustment for confounding factors (Table 1b) . We also found nominally significant association of allele at À3860 (P ¼ 0.037) in NOB-HT, which did not persist after correction for multiple testing. Genotypes of three other SNPs and alleles of À4112A/T and À242C/T did not show any significant differences between healthy subjects and NOB-HT. Genotypes and alleles of four SNPs did not show any significant differences between healthy subjects and OB-HT (data not shown).
Four SNPs were in strong and highly significant linkage disequilibrium with each other. The distributions of major haplotypes (H1-H5) between the healthy subjects and NOB-HT group revealed higher frequency of H3 haplotype (a-a-c-c) in NOB-HT that include the À6951 variant with nominal significance (P ¼ 0.048) (Supplementary Table 3 ). However, the association was no longer significant after correction for multiple testing. Haplotype combinations (diplotype) did not show any significant differences between healthy subjects and NOB-HT (data not shown).
Most of the difficulties in case-control and linkage studies have been attributed to genetic heterogeneity, including ethnic and disease aetiology. Essential hypertension is a heterogeneous disorder where several overlapping subsets of mechanisms may underlie the condition. Pausova et al. 4 performed genome-wide scans in French Canadians and found that the loci for the obesityassociated hypertension were significantly different from those for hypertension in nonobese individuals. Therefore, it seems quite reasonable for us to stratify hypertensive patients according to their BMI. Several studies already implicated the association of certain gene polymorphisms with essential hypertension after stratifying the subjects according to BMI. 8, 9 Our results also suggest that V1aR gene variation at À6951 may confer susceptibility to essential hypertension independent of obesity.
Dividing hypertensive individuals by ethnicity has also been shown to reduce the level of genetic heterogeneity. Morris 10 stated that Pausova et al. 4 succeeded to elevate the degree of genetic homogeneity by recruiting an isolated population from the geographically remote French-Canadian Saguenay/Lac-St-Jean region of Quebec. In the present study, all subjects were native Japanese residents in the rural district, Aomori prefecture, with a traditional, conservative and agriculture-based lifestyle. Therefore, it is likely that our relatively small, isolated population has also been spared from the level of genetic 'noise' present in mixed populations elsewhere. The relative risk associated with carriers of GA+AA of À6951G/A has been estimated vs GG genotype.
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Among several reports on microsatellite and SNPs in the V1aR gene and its 5 0 upstream, Thibonnier et al.
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found that V1aR gene microsatellite polymorphisms were not associated with essential hypertension in French Caucasians. They did not dissect hypertension by obesity or ethnicity. Although none of the microsatellite polymorphisms were found in our Japanese subjects, it appears to be an interesting question whether those variations have any association with nonobese hypertension in the French population. The promoter of V1aR gene plays a key role in regulating its expression associated with affiliative behaviour in rodents. 12 Among the four SNPs in the present study, three are located within some transcription factor response elements according to our computational analysis. Therefore, these SNPs might affect the transcriptional activity of V1aR gene.
In conclusion, the present study demonstrates a significant association of the V1aR SNP À6951 with essential hypertension in nonobese individuals. Therefore, the presence of V1aR gene variations might lead to an increased risk of hypertension in nonobese, but not in obese Japanese individuals.
